This is a major attempt to discredit a very reputable bio venture management team that has taken over AXDX... there is absolutely nothing to the research provided by Citron Research... they have no biotechnology expertise to draw from... the recent SEC correspondence DID NOT shine any new light on the ID/AST technology underdevelopment... there has been no "exposure of fraud"... the technology works as described... and will be a "game changing" technology that will meet vast acceptance once clinical testing is complete and FDA approval is met...
The shareholder lawsuits but the ambulance chasing law firms... is only part of the SHORT selling strategy...
Despite all of this noise... AXDX continues to get significant government grant funding from NIH... and its collaborative partners include the prestigious Washington University School of Medicine in St. Louis...
This is a development stage biotechnology firm... there are little if any revenues... it is well capitalized... and well managed... the technology continues to demonstrate significant reduction in time of identification of multi-drug resistant bacteria... the technology has just received ISA 13485:2003 certifications on its initial installation... and continued expansion of its partner utilization network is occurring at present to gather more testing feedback on the device and technologies applications...
You might very well utilize this very well coordinated SHORT SCARE to find a great entry point for a company that will see PPS between $45 to $70 by mid to late 2016... when the product (which is a razor / razor blade product model)... is fully being marketed with a potential market of every hospital and micro/molecular laboratory in North America... then Europe... then Asia... then everywhere else...
GO AXDX!!!
Recent AXDX News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:10:34 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/12/2024 09:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:30:56 PM
- Accelerate Diagnostics Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:01:29 PM
- Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial • PR Newswire (US) • 08/08/2024 08:00:00 PM
- Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results • PR Newswire (US) • 08/08/2024 03:09:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:16:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 09:06:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:25:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:15:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:10:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/23/2024 11:17:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 11:03:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 09:25:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:06:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:06:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:03:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:03:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:02:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:00:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:59:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 10:57:28 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM